Liquidia Corporation (LQDA)
LQDA Stock Price Chart
Explore Liquidia Corporation interactive price chart. Choose custom timeframes to analyze LQDA price movements and trends.
LQDA Company Profile
Discover essential business fundamentals and corporate details for Liquidia Corporation (LQDA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Jul 2018
Employees
170.00
Website
https://www.liquidia.comCEO
Roger A. Jeffs
Description
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
LQDA Financial Timeline
Browse a chronological timeline of Liquidia Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is $0.76, while revenue estimate is $168.48m.
Earnings released on 11 May 2026
EPS came in at $0.52 surpassing the estimated $0.34 by +52.94%, while revenue for the quarter reached $132.87m , beating expectations by +11.24%.
Earnings released on 5 Mar 2026
EPS came in at $0.15 surpassing the estimated $0.08 by +87.50%, while revenue for the quarter reached $92.02m , beating expectations by +3.88%.
Earnings released on 3 Nov 2025
EPS came in at -$0.04 surpassing the estimated -$0.45 by +91.11%, while revenue for the quarter reached $54.34m , missing expectations by -32.68%.
Earnings released on 12 Aug 2025
EPS came in at -$0.49 falling short of the estimated -$0.43 by -13.95%, while revenue for the quarter reached $8.84m , missing expectations by -38.20%.
Earnings released on 8 May 2025
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%, while revenue for the quarter reached $3.12m , missing expectations by -25.02%.
Earnings released on 19 Mar 2025
EPS came in at -$0.46 falling short of the estimated -$0.38 by -21.05%, while revenue for the quarter reached $2.92m , missing expectations by -11.99%.
Earnings released on 13 Nov 2024
EPS came in at -$0.37 matching the estimated -$0.37, while revenue for the quarter reached $4.45m , missing expectations by -4.01%.
Earnings released on 7 Aug 2024
EPS came in at -$0.37 falling short of the estimated -$0.35 by -5.71%, while revenue for the quarter reached $3.66m , missing expectations by -61.28%.
Earnings released on 13 May 2024
EPS came in at -$0.54 falling short of the estimated -$0.32 by -68.75%, while revenue for the quarter reached $2.97m , missing expectations by -33.58%.
Earnings released on 13 Mar 2024
EPS came in at -$0.42 falling short of the estimated -$0.23 by -82.61%, while revenue for the quarter reached $4.53m , missing expectations by -4.21%.
Earnings released on 7 Nov 2023
EPS came in at -$0.24 falling short of the estimated -$0.20 by -20.00%, while revenue for the quarter reached $3.68m , missing expectations by -23.22%.
Earnings released on 10 Aug 2023
EPS came in at -$0.36 falling short of the estimated -$0.17 by -111.76%, while revenue for the quarter reached $4.79m , beating expectations by +10.91%.
Earnings released on 4 May 2023
EPS came in at -$0.18 matching the estimated -$0.18, while revenue for the quarter reached $4.49m , beating expectations by +13.82%.
Earnings released on 16 Mar 2023
EPS came in at -$0.09 surpassing the estimated -$0.17 by +47.06%, while revenue for the quarter reached $5.36m , beating expectations by +50.84%.
Earnings released on 8 Nov 2022
EPS came in at -$0.14 surpassing the estimated -$0.18 by +22.22%, while revenue for the quarter reached $3.17m , missing expectations by -15.83%.
Earnings released on 11 Aug 2022
EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%, while revenue for the quarter reached $3.92m , beating expectations by +9.18%.
Earnings released on 12 May 2022
EPS came in at -$0.30 falling short of the estimated -$0.20 by -50.00%, while revenue for the quarter reached $3.49m , beating expectations by +5.95%.
Earnings released on 17 Mar 2022
EPS came in at -$0.23 falling short of the estimated -$0.11 by -109.09%, while revenue for the quarter reached $3.22m , beating expectations by +5.54%.
Earnings released on 3 Nov 2021
EPS came in at -$0.14 falling short of the estimated -$0.12 by -16.67%, while revenue for the quarter reached $3.18m , missing expectations by -26.59%.
Earnings released on 10 Aug 2021
EPS came in at -$0.13 surpassing the estimated -$0.16 by +18.75%, while revenue for the quarter reached $3.38m , beating expectations by 0.00%.
LQDA Stock Performance
Access detailed LQDA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
